AKT1 and endometrial cancer: Therefore, visfatin was found to promote the progression of endometrial cancer through Protein Kinase B(Akt) /phosphoinositide 3-kinases (PI3K) and extracellular-signal-regulated kinase/ mitogen activated protein kinase (ERK/MAPK) signaling.